MEDICAL ONCOLOGY HEMATOLOGY CONSULTANTS PA
NPI 1235199316, organization, Newark, DE, Internal Medicine, Hematology & Oncology
Public list actions
Paid after the action
Months in which Medicaid paid claims for this provider after a public action that should have triggered a screening check. This is a record of payments, not a determination that they were improper.
| list | identity check | action date | window closed | months paid after | first | last | paid after | 12 months before |
|---|---|---|---|---|---|---|---|---|
| Medicare revocation list 424.535(a)(1) noncompliance (dme standards not met) | Exact NPI, name verified | Apr 1, 2021 | Sep 5, 2026 | 44 | May 2021 | Dec 2024 | $8.8M | $643K |
National provider registry
From the CMS NPPES Registry, refreshed daily.
| Name | MEDICAL ONCOLOGY HEMATOLOGY CONSULTANTS PA |
| Type | Organization |
| Status | Active |
| NPI issued | March 24, 2006, last updated May 4, 2018 |
| Practice location | 4701 OGLETOWN STANTON RD, SUITE 2200, Newark, DE 19713-2055, 302-366-1200 |
| Authorized official | AMDREW HIMELSTEIN (President) |
| Specialties | Internal Medicine, Hematology & Oncology (207RH0003X, primary) |
Procedures billed
The specific codes behind the dollars. Medicaid figures come from T-MSIS (2018 to 2024) and are compared with every other provider billing the same code; Medicare figures come from the 2024 physician and supplier file and compare this provider's submitted charge with what Medicare allowed, against the usual ratio for that code.
| code | what it is | paid | share | per patient-month | typical | rank among providers | |
|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | $6.8M | 76% | $12K | $8K (top 5% from $16K) | 80th percentile | |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | $456K | 5% | $151 | $120 (top 5% from $408) | 64th percentile | |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | $333K | 4% | $74 | $60 (top 5% from $133) | 69th percentile | |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | $259K | 3% | $472 | too few months to rank | ||
| J1437 | Injection, ferric derisomaltose, 10 mg | $210K | 2% | $1K | too few months to rank | ||
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | $174K | 2% | $50 | $44 (top 5% from $110) | 61st percentile | |
| J0897 | Injection, denosumab, 1 mg | $167K | 2% | $2K | $689 (top 5% from $2K) | 91st percentile | |
| 99215 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or morehistory of abuse | $133K | 1% | $102 | $88 (top 5% from $210) | 60th percentile |
In this area
7 providers in New Castle County, DE carry an indicator in the public record, with $643K at stake between them. The most common is more hours than a day holds, on 5 of them, followed by named in an enforcement record on 1.
| tier | provider | at stake | why |
|---|---|---|---|
| 2 | RITU RASTOGI Wilmington, DE, ranked 744 | $316K |
|
| 3 | SHAYASTA MUFTI Bear, DE, ranked 5349 | $0 |
|
| 4 | QAYYUM NAZAR Bear, DE, ranked 8019 | $227K |
|
| 4 | NIEEMA MAHDI Wilmington, DE, ranked 8390 | $55K |
|
| 4 | MELISSA SCHNECK Wilmington, DE, ranked 9765 | $3K |
|
| 4 | MALIKA MCMEANS SPRUILL Townsend, DE, ranked 9776 | $617 |
|
| 5 | BIOTEK REMEDYS, INC. New Castle, DE, ranked 11792 | $41K |
Recent enforcement in DE
All releasesDepartment of Justice and HHS-OIG releases for this state, newest first. Each opens in a new tab.
Referral packet
The packet is a draft for a reviewer. It reads every public record behind this case, states what the records show with a citation for each finding, names the regulation each finding relates to, and lists the ordinary explanations to rule out first. It never asserts intent.